Ładuje się......
Mesenchymal stem cells-bridge catalyst between innate and adaptive immunity in COVID 19
Majority of patients infected with the COVID 19 virus display a mild to moderate course of disease and spontaneously recover at 14–20 days. However, about 15% of patients progress to severe stages and 2.5% of these patients succumb to this illness. Most patients with severe disease belong to the eld...
Zapisane w:
| Wydane w: | Med Hypotheses |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Published by Elsevier Ltd.
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7232064/ https://ncbi.nlm.nih.gov/pubmed/32425307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2020.109845 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|